INSTEM Announces Extension of Research Collaboration Agreement with U.S. FDA to 2031

Contributed by: Business Wire

Logo

Tags

Biotechnology

Technology

FDA

Professional Services

Health

Pharmaceutical

Research

Data Analytics

Software

Science

Clinical Trials

U.S. FDA

More Like This

Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

Instem Unveils New Global Headquarters in Boston, MA

Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee

PR Newswire associated0

Accorto Regulatory Solutions and Inter Scientific Enter Strategic Alliance to Deliver an Integrated Single-Point Solution for Clients

Climb’s Innovation Continues at Instem

RQM+ Launches SMART Solutions Life Cycle Partnership Model

Instem Announces Provantis® 12: A Powerful Step Forward in Preclinical Study Management